ABBV/ENTA—3Q15 worldwide V-Pak sales of $469M increased 21% from 2Q15 and now represent an annualized rate of $1.9B. ABBV is apparently maintaining its guidance that V-Pak will have a worldwide annualized run rate >$3B as of 12/31/15. ABBV’s 3Q15 PR: http://finance.yahoo.com/news/abbvie-reports-third-quarter-2015-105500521.html